Rating Change
Wells Fargo reiterated its Equal-Weight rating on Bristol-Myers Squibb Company (NYSE:BMY) on October 13, 2026.
reiterateNYSE:BMY
Wells Fargo Reiterates Equal-Weight Rating on Bristol-Myers Squibb Company (BMY)
Wells Fargo reiterated its Equal-Weight rating on Bristol-Myers Squibb Company (NYSE:BMY) on October 13, 2026.
At publication ·
What changed
Bristol-Myers Squibb Company (NYSE:BMY) · reiterate
- Firm
- Wells Fargo
- Rating
- Equal-Weight to Equal-Weight
- Price at event
- $56.67
- Market capitalization
- $104.2B
At a glance
Key takeaways
- Wells Fargo maintained an Equal-Weight rating on Bristol-Myers Squibb (BMY) on October 13, 2026, indicating neutral sentiment on the stock.
Market Context
Bristol-Myers Squibb Company operates in the Healthcare sector. The stock currently trades at $56.67 with a market capitalization of $104.2B. The stock has gained 3.7% over the past 52 weeks.
Analyst coverage from Wells Fargo provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Bristol-Myers Squibb Company.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Bristol-Myers Squibb Company
Among the 10 most recent ratings: 3 Buy, 6 Hold, 1 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 13, 2026 | Wells Fargo | Equal-Weight | N/A |
| Oct 08, 2026 | Cantor Fitzgerald | Neutral | N/A |
| Oct 07, 2026 | Morgan Stanley | Underweight | N/A |
| Oct 05, 2026 | Leerink Partners | Market Perform | N/A |
| Sep 16, 2026 | Piper Sandler | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View BMY Stock Page
Frequently Asked Questions
What does the Equal-Weight rating mean for BMY?
A rating of Equal-Weight from Wells Fargo reflects the analyst's outlook on Bristol-Myers Squibb Company (NYSE:BMY). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the BMY forecast page.
